NSCLC, STAGE I
Clinical trials for NSCLC, STAGE I explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE I trials appear
Sign up with your email to follow new studies for NSCLC, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an immunotherapy drug stop early lung cancer from returning after surgery?
Disease control Recruiting nowThis study looks at whether giving the drug pembrolizumab after surgery can help keep stage I lung cancer from returning. About 244 people who had their tumor removed will either receive pembrolizumab every 6 weeks for about a year or just be watched. The goal is to see if the dr…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Greg Durm, MD • Aim: Disease control
Last updated May 26, 2026 04:58 UTC
-
New combo aims to shield scarred lungs during cancer radiation
Disease control Recruiting nowThis study tests whether adding the drug BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 participants will receive both t…
Matched conditions: NSCLC, STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC